Sara A. Byron
- Molecular Biology top 5%
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- John D. CarptenDavid W. CraigPamela M. PollockKendall Van Keuren‐JensenDavid M. EngelthalerMichael G. GartsideCandice L. WellensPaul J. Goodfellow
- Topics
- Cancer Genomics and Diagnostics (15 papers)Fibroblast Growth Factor Research (13 papers)Glioma Diagnosis and Treatment (6 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Sara A. Byron
47 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 1.3k
- Cancer Research 549
- Oncology 375
- Pulmonary and Respiratory Medicine 223
- Pathology and Forensic Medicine 179
Countries citing papers authored by Sara A. Byron
This map shows the geographic impact of Sara A. Byron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara A. Byron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara A. Byron more than expected).
Fields of papers citing papers by Sara A. Byron
This network shows the impact of papers produced by Sara A. Byron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara A. Byron. The network helps show where Sara A. Byron may publish in the future.
Co-authorship network of co-authors of Sara A. Byron
This figure shows the co-authorship network connecting the top 25 collaborators of Sara A. Byron. A scholar is included among the top collaborators of Sara A. Byron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara A. Byron. Sara A. Byron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 6 | |
| 6 | 14 | |
| 7 | 8 | |
| 8 | 41 | |
| 9 | 12 | |
| 10 | Translating RNA sequencing into clinical diagnostics: opportunities and challengesbreakdown → | 504 |
| 11 | 157 | |
| 12 | 2 | |
| 13 | 38 | |
| 14 | 140 | |
| 15 | 1 | |
| 16 | 37 | |
| 17 | 102 | |
| 18 | 38 | |
| 19 | 119 | |
| 20 | Inhibition of FGFR2 in endometrial cancer cells induced apoptosis despite constitutive activation of the PI3K/AKT pathway. | 1 |
About Sara A. Byron
Sara A. Byron is a scholar working on Cancer Research, Structural Biology and Genetics, having authored 48 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), Fibroblast Growth Factor Research (13 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Cancer Research (549 citations), Molecular Biology (1.3k citations) and Obstetrics and Gynecology (147 citations). Sara A. Byron has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include John D. Carpten, David W. Craig, Pamela M. Pollock, Kendall Van Keuren‐Jensen, David M. Engelthaler, Michael G. Gartside, Candice L. Wellens, Paul J. Goodfellow, Matthew A. Powell and David G. Mutch. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Nature Reviews Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.